Author: svadmin

Posted on

Mindray lance le système d’échographie Resona I9 et révolutionne l’imagerie générale

SHENZHEN, Chine, 17 juin 2021 /PRNewswire/ — Mindray (SZSE: 300760), l’un des principaux développeurs et fournisseurs mondiaux de dispositifs et de solutions médicaux, a annoncé le lancement de son nouveau système d’échographie diagnostique d’imagerie générale, Resona I9, rattaché à sa suite de solutions d’imagerie générale. Bénéficiant d’innovations tant à l’intérieur qu’à l’extérieur, le système Resona I9 fournit aux cliniciens des réponses précises et opportunes, tout en offrant une efficacité exceptionnelle et une expérience utilisateur remarquable.

Mindray Launches Resona I9 Ultrasound System, Revolutionizing General Imaging

Le système Resona I9 a été développé sur la base des connaissances approfondies de Mindray sur les scénarios cliniques complexes. Système d’échographie de pointe, il est équipé de toutes les technologies les plus récentes. Offrant une innovation dans tous les domaines, le système Resona I9 est doté d’un panneau de commande personnalisable, d’une structure pliable d’un mètre de hauteur, d’une autonomie prolongée et d’une conception favorisant un fonctionnement très silencieux. Tous ces éléments contribuent à réduire la fatigue au minimum pendant les acquisitions. La plateforme révolutionnaire ZST+ de Mindray alimente le système et l’élève à un niveau inégalé dans sa catégorie en offrant une qualité d’image exceptionnelle pour des solutions d’imagerie infinies.

« Chez Mindray, nous nous efforçons constamment de fournir de meilleures solutions de soins de santé aux cliniciens. Pour ce faire, nous devons comprendre en profondeur nos clients, être inspirés par leur travail quotidien et tirer parti de ces connaissances pour proposer des innovations qui font une différence dans leur flux de travail. Le système Resona I9 a évolué avec les exigences en évolution de l’imagerie diagnostique et comprend une suite de fonctionnalités innovantes, toutes alimentées par notre plateforme ZST+ avancée », a déclaré He Xujin, directeur général de la division dédiée à l’imagerie médicale de Mindray.

Le panneau de commande iConsole du Resona I9 bénéficie d’une conception révolutionnaire et d’une configuration adaptative, modulable en fonction de différents scénarios cliniques. Ses touches E-ink sont personnalisables pour les fonctions les plus fréquemment utilisées pendant les acquisitions, tandis que le panneau de commande flottant multidirectionnel peut être ajusté pour une meilleure utilisation de l’espace permettant au système Resona I9 de répondre facilement à divers besoins d’acquisition pour les patients. Ces éléments de conception révolutionnaires offrent de nouvelles possibilités pour les examens échographiques et améliorent l’efficacité du flux de travail dès le début.

Le STE (speckle tracking échocardiographique) à cadence d’imagerie élevée (HiFR) de la solution produit des ondes de cisaillement constantes et une évaluation précise de la rigidité des tissus pour une détection de mouvement plus sensible, ce qui permet une plus grande stabilité et précision pendant les acquisitions. Le système Resona I9 est également équipé des fonctions d’analyse automatique des lésions standard Smart Breast et Smart Thyroid. Les temps d’examen sont réduits et l’acquisition est plus efficace.

Avec ses fonctionnalités innovantes et sa flexibilité d’acquisition illimitée, le Resona I9 de Mindray fournit aux cliniciens les outils complets nécessaires pour un traitement diagnostique plus précis, permettant une fiabilité diagnostique accrue pour de meilleurs soins aux patients.

Photo – https://mma.prnewswire.com/media/1523864/image_1.jpg

Posted on

Vytelle Completes Research with the Agricultural Research Council-Animal Production

KANSAS CITY, Missouri, June 17, 2021 (GLOBE NEWSWIRE) — Vytelle and the Agricultural Research Council (ARC) announce today the demonstrated accuracy and reliability of In-Pen Weighing Positions with the use of appropriate conversion factors for native South African cattle breeds and crosses. The use of In-Pen Weighing Positions reduces labor requirements associated with chute weight collection, stress, and injury in animals and handlers.

Nicky Lansink, SENSE Product Manager for Vytelle commented on the pitfalls of chute weights alone, “The challenge is that, although chute weights may be correct, they are not accurate since there can be large variations between consecutive weights of the same animal.”

Data was collected at the ARC Animal Production facility in Pretoria, South Africa, from October 2017 to December 2020 over several different trials.

Data was collected on bulls from 18 different breeds, including purebred and crossbred animals of the following breeds: Afrikaner, Angus, Bonsmara, Brahman, Holstein, Nguni, Simbrah and Simmentaler with an average weight of 342 kg (Std Dev = 86 kg), and a minimum and maximum weight of 142 kg and 630 kg, respectively.

Animals were on trial for at least 70 days, with a maximum trial length of 203 days. On average, animals were chute weighed every 11 days during the trial period and on average each animal had 12 chute weights collected.

“This study was specifically designed to learn the accuracy of estimated full body weights for native South African cattle breeds and its crosses with Vytelle’s In-Pen Weighing Positions. More than 4,000 records demonstrated In-Pen Weighing Positions accurately and reliably measure body weights of cattle from South African breeds, when the appropriate conversion factors are used,” said Professor Scholtz, of the Agricultural Research Council.

The In-Pen Weighing Position measures individual animal partial body weight and growth. It weighs every second an animal is standing at the water trough, which can equate up to 450 weights a day.

Vytelle’s In-Pen Weighing Positions and integrated livestock technology platform is available globally to cattle producers. Visit www.vytelle.com to learn more.

About Vytelle

Vytelle is a precision livestock company reshaping how cattle producers worldwide optimize their herds. Through Vytelle’s integrated technology platform, generations of genetic gains can be made in just a few years. This allows producers to sustainably deliver more protein with fewer inputs, helping to ensure meat and milk are viable, competitive food choices for future generations.

Attachments

Danielle Starr
Vytelle
+1 816 886 8363
[email protected]
Posted on

Synchronoss Announces CFO Transition Plan

Company Reaffirms Fiscal Year 2021 Guidance

BRIDGEWATER, N.J., June 16, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and digital products and platforms, today announced a CFO transition plan with current Chief Financial Officer (CFO) David Clark stepping down from his role on August 9, 2021, to pursue other personal and career interests. Clark’s transition is unrelated to the Company’s financial reporting and business performance, and the Company is reaffirming 2021 guidance previously provided on May 10, 2021, in parallel with today’s announcement. Clark was appointed CFO in August 2018.

Commenting on Clark’s departure, Jeff Miller, President and CEO of Synchronoss, said: “I’ve enjoyed working alongside David and thank him for his commitment to the Company. David joined Synchronoss to make enhancements to our operational controls and reporting. During his tenure he has helped Synchronoss navigate successfully through significant improvements in management of operating expenses and implementation of financial governance and controls. I firmly believe his contributions have positioned us for future growth and success. On a personal note, I wish him only the best with his future endeavors and appreciate his support during this leadership transition.”

An executive search for Clark’s replacement is currently underway. He will remain in his current role until his departure date and will support Synchronoss as it transitions the CFO role to a successor.

About Synchronoss
Synchronoss Technologies (NASDAQ: SNCR) builds software that empowers companies around the world to connect with their subscribers in trusted and meaningful ways. The company’s collection of products helps streamline networks, simplify onboarding and engage subscribers to unleash new revenue streams, reduce costs and increase speed to market. Hundreds of millions of subscribers trust Synchronoss products to stay in sync with the people, services and content they love. That’s why more than 1,500 talented Synchronoss employees worldwide strive each day to reimagine a world in sync. Learn more at www.synchronoss.com

Forward-Looking Statements

This press release includes statements concerning Synchronoss and its future expectations, plans and prospects that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “believes,” “potential” or “continue” or other similar expressions are intended to identify forward-looking statements. Synchronoss has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its business, financial condition and results of operations. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions including, without limitation, risks relating to the Company’s ability to sustain or increase revenue from its larger customers and generate revenue from new customers, the Company’s expectations regarding expenses and revenue, the sufficiency of the Company’s cash resources, the Company’s growth strategies, the anticipated trends and challenges in the business and the market in which the Company operates, the Company’s expectations regarding federal, state and foreign regulatory requirements, the pending lawsuits against the Company described in its most recent SEC filings, and other risks and factors that are described in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, which are on file with the SEC and available on the SEC’s website at www.sec.gov. The company does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

Media Contacts

For Synchronoss:
Anais Merlin, CCgroup UK
Diane Rose, CCgroup US
E: [email protected]

Investor Contact
For Synchronoss: Todd Kehrli/Joo-Hun Kim, MKR Investor Relations, Inc., E: [email protected]

Posted on

Nikkiso Cryogenic Services anuncia que Asas Aljood (Arábia Saudita) será seu Prestador de Serviços Autorizado

TEMECULA, Califórnia, June 16, 2021 (GLOBE NEWSWIRE) — O Clean Energy & Industrial Gases Group (“Grupo”) da Nikkiso Cryogenic Industries, subsidiária da Nikkiso Co., Ltd (Japão), tem o orgulho de anunciar a assinatura de um acordo para que a Asas Aljood se torne a Prestadora de Serviços Autorizada da Nikkiso Cryogenic Services (NCS) no Reino da Arábia Saudita.

Com o crescimento do mercado do Oriente Médio, este acordo permite que o Grupo amplie sua presença regional para as indústrias de gases industriais, hidrogênio, processamento de gás natural e petroquímica. A partir de 1º de julho de 2021, a Asas Aljood utilizará suas oficinas locais para oferecer serviço pós-venda e suporte de bombas e expansores turbo, incluindo embalagens, reparos, peças sobressalentes e serviço de campo.

Com sede em Dammam, a Asas Aljood irá fortalecer nossa presença regional existente, além da operação do Grupo no Oriente Médio em Sharjah (EAU).

“A parceria recém-formada da Nikkiso com a Asas Aljood permite que tenhamos uma forte presença regional na Arábia Saudita e fortalece nossa capacidade de servir melhor os mercados do Oriente Médio”, disse Jim Estes, Presidente da Nikkiso Cryogenic Services. “Estamos prontos para continuar a oferecer aos clientes da Nikkiso um serviço e suporte de alta qualidade, eliminando tempos de inatividade dispendiosos para suas operações e processos.”

A Asas Aljood é provedora líder de serviços de suporte e manutenção nas indústrias de petróleo e gás, petroquímica e energia, entre outras.

SOBRE A CRYOGENIC INDUSTRIES
A Cryogenic Industries, Inc. (agora membro da Nikkiso Co., Ltd.) fabrica equipamentos de processamento de gás criogênico projetados e plantas de processo de pequena escala para as indústrias de gás natural liquefeito (GNL), serviços de poços e gás industrial. Fundada há mais de 50 anos, a Cryogenic Industries é a empresa controladora da ACD, Cosmodyne e Cryoquip e de um grupo comumente controlado de aproximadamente 20 entidades operacionais.

Para mais informações, visite www.nikkisoCEIG.com e www.nikkiso.com.

CONTATO COM A MÍDIA:

Anna Quigley
+1.951.383.3314
[email protected]

Posted on

Nikkiso Cryogenic Services annonce qu’Asas Aljood (Arabie saoudite) deviendra son Fournisseur de services agréé

TEMECULA, Californie, 16 juin 2021 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (le « Groupe »), une filiale de Nikkiso Co., Ltd (Japon), est fière d’annoncer la signature d’un accord pour qu’Asas Aljood devienne le Fournisseur de services agréé de Nikkiso Cryogenic Services (NCS) dans le Royaume d’Arabie saoudite.

Avec la croissance du marché au Moyen-Orient, cet accord permet au Groupe d’étendre sa présence régionale auprès des industries des gaz industriels, de l’hydrogène, du traitement du gaz naturel et de la pétrochimie. À partir du 1er juillet 2021, Asas Aljood utilisera ses ateliers locaux pour offrir un service après-vente et une assistance pour les pompes et les turbodétendeurs, y compris les emballages, les réparations, les pièces de rechange et le service sur site.

Asas Aljood, dont le siège social est basé à Dammam, nous aidera à renforcer notre présence régionale existante en plus des activités du Groupe au Moyen-Orient à Charjah (ÉAU).

« Le partenariat nouvellement formé avec Nikkiso et Asas Aljood nous confère une forte présence régionale en Arabie saoudite et renforce notre capacité à mieux servir les marchés du Moyen-Orient », a déclaré Jim Estes, président de Nikkiso Cryogenic Services. « Je suis impatient de continuer à fournir aux clients de Nikkiso un service et une assistance de la plus haute qualité en éliminant les temps d’arrêt coûteux de leurs opérations et processus. »

Asas Aljood est un fournisseur de premier plan de services d’assistance et d’entretien dans les secteurs du pétrole et du gaz, de la pétrochimie et de l’énergie, entre autres.

À PROPOS DE CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (aujourd’hui membre de Nikkiso Co., Ltd) et ses entreprises membres fabriquent des équipements et petites usines de traitement du gaz cryogénique pour les secteurs du gaz naturel liquéfié (GNL), des services d’entretien de puits et du gaz industriel. Fondée il y a plus de 50 ans, Cryogenic Industries est la société-mère d’ACD, de Cosmodyne et de Cryoquip, ainsi qu’un groupe administré en commun comptant une vingtaine d’entités opérationnelles.

Pour tout complément d’information, veuillez consulter les sites www.nikkisoCEIG.com et www.nikkiso.com.

CONTACT AUPRÈS DES MÉDIAS :

Anna Quigley
+1.951.383.3314
[email protected]

Posted on

Former Nigerian President Obasanjo Joins Global Oncology To Commit to a Cervical Cancer-Free Future for Nigerian Women

President Obasanjo’s role as Cervical Cancer-Free Nigeria Campaign Ambassador will accelerate broad-scale vaccination of Nigerians against HPV, the virus that causes cervical cancer

SAN FRANCISCO, CA / ACCESSWIRE / June 16, 2021 / Global Oncology, a U.S.-based non-profit organization announces the appointment of Former Nigerian President Olusegun Obasanjo as Presidential Ambassador of the Cervical Cancer-Free Nigeria campaign (www.CervicalCancerFree.org). The grassroots campaign is mobilizing communities across Nigeria to improve access to and uptake of the HPV vaccine, which will help achieve the WHO’s target of a cervical-cancer free future – the first global commitment to eliminate a cancer.Africa1

“Women are the cornerstone of Nigerian society – we must commit to their health and well-being. I am thus honored to partner with Global Oncology to advance the Cervical Cancer-Free Nigeria campaign,” said President Obasanjo. “I am confident that Nigeria can lead the charge in achieving the WHO goal of vaccinating at least 90% of girls by 2030. We must raise awareness and end this disease once and for all.”

Cervical cancer is the second-most common cancer in Nigeria and three Nigerian women die of the disease every day. These deaths are preventable with the HPV vaccine, scheduled for introduction in Nigeria in 2021. Previous research has clearly shown that the success of a vaccine rollout – whether it is the HPV vaccine or COVID-19 vaccine – depends on the general public being made aware of vaccine safety, efficacy and availability. To address this critical need, Global Oncology and its partner organizations have developed innovative educational tools and advocacy strategies to ensure that there is a high level of awareness, readiness and uptake of the HPV vaccine when it is rolled out nationally.

Dr. Ami S. Bhatt, Co-founder of Global Oncology and Associate Professor of Medicine and Genetics at Stanford University, said, “We are so fortunate that President Obasanjo has so passionately committed to improve the lives of women and girls across Nigeria as a part of the Cervical Cancer-Free Nigeria campaign. He will no doubt accelerate progress and ensure the success of this life-saving effort.”

Other distinguished Nigerian Ambassadors of the CCFN campaign include Otunba Abimbola Ogunbanjo, President of the National Council of The Nigerian Stock Exchange; Senator LanreTejuoso, Pro-Chancellor of the University of Lagos and President of the Legislative Initiative for Sustainable Development; Dr. Zainab ShinkafiBagudu, First Lady of Kebbi State and Founder and CEO of Medicaid Cancer Foundation; Mr. Patrick Doyle, Broadcaster and producer; Ms. Rekiya Ibrahim Attah, Actress; Ms. TounSonaiya, Radio broadcaster and CEO of WFM 91.7; Ms. Tinu Eze, Teacher and mentor; Ms. Amarachi Nwosu, Creative director and cultural consultant; Ms. Karo Omu, Founder of Sanitary Aid Initiative; and Ms. Folashade Domingo, Health advocate.

About Global Oncology

Global Oncology (http://globalonc.org) was founded by Drs. Ami Bhatt (Stanford University) (bio) and Franklin Huang (University of California, San Francisco) (bio) in 2012 and is based in the San Francisco, California, USA. They seek to bring the best in cancer care and education to underserved communities worldwide.

CONTACT: 
Phil Garrity, GO Program Director
[email protected]
m: 617-899-9963

Mr. Kehinde Akinyemi, Special Assistant on Media to President Obasanjo
[email protected]

SOURCE: Global Oncology, Inc.